Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Cross-Cultural Translation into Brazilian Portuguese and Validation of the Oral Anticoagulation Knowledge Tool (AKT-Br).

Authors:
Felipe F Mainka Vinicius L Ferreira Antonio M Mendes Gustavo L Marques Cassyano J Correr Fernanda S Tonin Roberto Pontarolo

Braz J Cardiovasc Surg 2022 05 23;37(3):356-369. Epub 2022 May 23.

Department of Pharmacy, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.

Introduction: Oral anticoagulants are the treatment of choice for diverse types of coagulation disorders. Warfarin is widely used by the Brazilian population, possibly due to its lower cost than other oral anticoagulants. However, it has a high risk of serious adverse effects if used incorrectly. The Anticoagulation Knowledge Tool (AKT) can assess a patient's knowledge about her/his oral anticoagulant therapy and can assist health professionals in identifying patients with difficulties in adherence. This study aimed to translate, culturally adapt, and validate the AKT into Brazilian Portuguese.

Methods: After a standard forward-backward procedure to translate the AKT into Brazilian Portuguese (AKT-Br), a version of the instrument was applied in three groups (patients, pharmacists, and the general population). The reliability of the AKT-Br was tested using an internal consistency measure and test-retest. The validity of the instrument was confirmed with data from the contrasted groups. All statistical analyses were performed with RStudio.

Results: The median scores obtained with the AKT-Br were 29.0, 17.0, and 7.5 for pharmacists, patients, and the general population, respectively (maximum score of 35 points). There was moderate internal consistency for the instrument and test-retest reliability was satisfactory. Analysis of variance for validity of the groups revealed a significant relationship between the total score and the evaluated groups.

Conclusion: The ATK-Br is a reliable and valid tool to assess knowledge about oral anticoagulants. AKT-Br can be used in clinical practice as an auxiliary tool to improve patient care through personalised educational interventions.

Download full-text PDF

Source
http://dx.doi.org/10.21470/1678-9741-2020-0731DOI Listing
May 2022

Publication Analysis

Top Keywords

oral anticoagulants
12
internal consistency
8
anticoagulation knowledge
8
general population
8
brazilian portuguese
8
akt brazilian
8
knowledge tool
8
oral
5
akt-br
5
procedure translate
4
translate akt
4
portuguese akt-br
4
revealed relationship
4
version instrument
4
akt-br version
4
standard forward-backward
4
cross-cultural translation
4
instrument applied
4
applied three
4
three groups
4

Keyword Occurance

Similar Publications

Health-related quali ty of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.

Authors:
Margaret C Fang Alan S Go Priya A Prasad Hui X Zhou Anna L Parks Dongjie Fan Cecilia Portugal Sue Hee Sung Kristi Reynolds

Thromb Res 2022 Jun 28;216:97-102. Epub 2022 Jun 28.

Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.

Introduction: Venous thromboembolism (VTE) is commonly treated with oral anticoagulants, including warfarin or direct oral anticoagulants (DOACs). Although DOACs are associated with favorable treatment satisfaction, few studies have assessed whether quality of life differs between DOAC and warfarin users.

Materials And Methods: We invited adults enrolled in two California-based integrated health care delivery systems and with a history of VTE between January 1, 2015 and June 30, 2018 to complete a survey on their experience with anticoagulants. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Randomized Trial of Surgical Left Atrial Appendage Closure: Protection Against Cerebrovascular Events.

Authors:
Christoffer V Madsen Jesper Park-Hansen Susanne J V Holme Akhmadjon Irmukhamedov Christian L Carranza Anders M Greve Gina Al-Farra Robert G C Riis Brian Nilsson Johan S R Clausen Anne S Nørskov Christina Kruuse Thomas C Truelsen Helena Dominguez

Semin Thorac Cardiovasc Surg 2022 Jun 28. Epub 2022 Jun 28.

Department of Cardiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark.

Following open-heart surgery, atrial fibrillation and stroke occur frequently. Left atrial appendage closure added to elective open-heart surgery could reduce the risk of ischemic stroke. We aim to examine if routine closure of the left atrial appendage in patients undergoing open-heart surgery provides long-term protection against cerebrovascular events independently of atrial fibrillation history, stroke risk, and oral anticoagulation use. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Impact of direct oral anticoagulant use on mortality in very old patients with non-valvular atrial fibrillation.

Authors:
Masahiko Takahashi Keisuke Okawa Takeshi Morimoto Ryu Tsushima Yuya Sudo Ai Sakamoto Masahiro Sogo Masatomo Ozaki Masayuki Doi Hiroshi Morita Ken Okumura Hiroshi Ito

Age Ageing 2022 Jul;51(7)

Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, Okayama 700-8558, Japan.

Background: the efficacy and safety of direct oral anticoagulants (DOACs) compared with that of warfarin in very old patients with non-valvular atrial fibrillation (NVAF) have been reported in terms of thromboembolisms and bleeding. However, the association of DOAC use and mortality in such patients remains unclear.

Objectives: this study aimed to investigate the incidence of mortality, as well as thromboembolisms and major bleeding, in very old patients with NVAF using DOACs as compared with warfarin. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.

Authors:
Anjana Mohan Zahra Majd Trang Trinh Rutugandha Paranjpe Susan M Abughosh

Int J Clin Pharm 2022 Jul 1. Epub 2022 Jul 1.

Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, 4849 Calhoun Rd Suite 4050, Houston, TX, USA.

Background: Poor adherence to oral anticoagulants is a significant problem in atrial fibrillation (AF) patients with comorbidities as it increases the risk for cardiac and thromboembolic events.

Aim: The primary objective was to evaluate adherence to direct oral anticoagulants (DOACs) or warfarin using group-based trajectory modeling (GBTM). The secondary objective was to identify the predictors of adherence to oral anticoagulants. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice.

Authors:
Ceder H van den Bosch Judith Spijkerman Marc H W A Wijnen Idske C L Kremer Hovinga Friederike A G Meyer-Wentrup Alida F W van der Steeg Marianne D van de Wetering Marta Fiocco Indra E Morsing Auke Beishuizen

Support Care Cancer 2022 Jul 1. Epub 2022 Jul 1.

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Purpose: The purpose of this study was to determine the most optimal central venous catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications.

Methods: A retrospective study including patients diagnosed with HL from 2015 to 2021 at the Princess Máxima Center was performed. Patients were followed from CVC insertion until removal or 06-2021, whichever came first. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap